Increased Incidence of New-Onset Diabetes Mellitus Type II Following Haploidentical Bone Marrow Transplant with Post-Transplant Cyclophosphamide for Sickle Cell Disease

Dilan A. Patel(Washington University in St. Louis), Adetola A. Kassim(Vanderbilt University), Leena Karnik, Reena Jayani(Vanderbilt University Medical Center), Stacey Goodman(Texas Oncology), Michael Byrne(Vanderbilt University Medical Center), Brian G. Engelhardt(Vanderbilt University Medical Center), Bhagirathbhai Dholaria(Vanderbilt University Medical Center), Carrie L. Kitko(Vanderbilt University Medical Center), Wichai Chinratanalab(VA Tennessee Valley Healthcare System), Michael P. Matheney(University of Tennessee Health Science Center), Katie S. Gatwood(Vanderbilt University Medical Center), Kathryn A. Culos(Vanderbilt University Medical Center), Salyka Sengsayadeth(VA Tennessee Valley Healthcare System), Bipin N. Savani(Vanderbilt University Medical Center), Jim Connelly, Josu de la Fuente(Imperial College Healthcare NHS Trust), Karina L Wilkerson(Vanderbilt University Medical Center), Heidi Chen(Vanderbilt University Medical Center)
Blood
November 4, 2020
Cited by 0


Related Papers